Matches in Nanopublications for { ?s ?p "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP59552.RAZZn4TPD9r9_1qE5RMrVjjhalDqiGuoo9i05Zd1uf7co130_assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59552.RAZZn4TPD9r9_1qE5RMrVjjhalDqiGuoo9i05Zd1uf7co130_provenance.
- assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP405957.RAS8Ht5IasDbD0STrjrAEzRDZ20sK4YGXNBZDwWMu6Yd8130_assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405957.RAS8Ht5IasDbD0STrjrAEzRDZ20sK4YGXNBZDwWMu6Yd8130_provenance.
- NP81299.RAEZ1rpp7k8zQFJlfBlESqNlfGceJNWXZYqV3fRVvvgyo130_assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP81299.RAEZ1rpp7k8zQFJlfBlESqNlfGceJNWXZYqV3fRVvvgyo130_provenance.
- NP405956.RA6hVqUj54-scKTacJ2f6ajrXGjc_mNymyft1XmjOoxLY130_assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405956.RA6hVqUj54-scKTacJ2f6ajrXGjc_mNymyft1XmjOoxLY130_provenance.
- NP405958.RA2PiE3XJxnaqSimBvziYjon_VpDpvaskjRkjoaZyD0zU130_assertion description "[Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405958.RA2PiE3XJxnaqSimBvziYjon_VpDpvaskjRkjoaZyD0zU130_provenance.